Fighting with obesity: the "gold standard" and new horizons

Data of the World Health Organization and numerous clinical studies have shown a steady increase in the prevalence of obesity in the world. The number of obese people has doubled in the last three decades. The increase in obesity prevalence with age was found in Russia in the large epidemiological study ESSE-RF. Besides, increase in obesity prevalence was observed among men. Special attention is necessary for patients with overweight or obesity in the primary prevention of chronic non-communicable diseases, such as cardiovascular disease and type 2 diabetes. Therapy aimed at addressing the risk factors of adverse outcomes is rational, if the patient has a disease associated with obesity.

• Publication year

  2016

• Venue

  Racionalʹnaâ Farmakoterapiâ v Kardiologii

• Publication date

  2016-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.20996/1819-6446-2016-12-4-450-458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Жалобы на нарушения дыхания во сне и факторы риска сердечно-сосудистых заболеваний в регионах России: данные исследования ЭССЕ-РФ

  2018cited by this paper
• JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda

  2016cited by this paper
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

  2016influential reference
• European Guidelines for Obesity Management in Adults

  2015cited by this paper
• SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment

  2015influential reference
• Losartan versus Telmisartan in Overweight Patients with Arterial Hypertension

  2015cited by this paper
• Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2014cited by this paper
• Prise en charge intensive du mode de vie et réduction du risque cardiovasculaire chez des patients diabétiques de type 2

  2014cited by this paper
• Recent advances in clinical practice challenges and opportunities in the management of obesity

  2014influential reference
• Pharmacotherapy Considerations in Diabetes and Obesity: Setting Patients up for Success

  2014cited by this paper
• Single‐Pill Combination of Telmisartan/Amlodipine in Patients With Severe Hypertension: Results From the TEAMSTA Severe HTN Study

  2012cited by this paper
• Telmisartan improves insulin sensitivity: a meta-analysis of randomized head-to-head trials.

  2012cited by this paper
• Body mass index, waist circumference, and risk of coronary heart disease: A prospective study among men and women.

  2010cited by this paper
• The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

  2010influential reference
• Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

  2009cited by this paper
• ONTARGET, TRANSCEND and PROFESS – Clarifying, confusing or misleading

  2009cited by this paper
• Telmisartan, ramipril, or both in patients at high risk for vascular events.

  2008cited by this paper
• ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides.

  2008cited by this paper
• ПАТОГЕНЕТИЧЕСКИЕ ВЗАИМОСВЯЗИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ И ИНСУЛИНОРЕЗИСТЕНТНОСТИ

  2006cited by this paper
• Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

  2005cited by this paper
• Waist circumference and not body mass index explains obesity-related health risk.

  2004influential reference
• Obesity, diet, and poverty: trends in the Russian transition to market economy

  2003influential reference
• A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue.

  1996cited by this paper
• Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men

  1994cited by this paper
• Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

  1984cited by this paper

• Relationship between personal anxiety and genes associated with eating disorders in women aged 45-64

  2024cites this paper
• Ovarian reserve in obese patients: where do the eggs disappear?

  2024cites this paper
• Heart failure with preserved left ventricular ejection fraction amidst diabetes mellitus: from general mechanisms to possible therapy tactics

  2022cites this paper
• Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases

  2021cites this paper
• Correlation between adipocytokine profile and heart rate variability in patients with obesity

  2020cites this paper
• Obesity treatment and adherence to doctors′ recommendations in patients with cardiovascular diseases and/or cardiovascular disease risk factors (results of patients’ interviews within the outpatient registry «PROFILE»)

  2019cites this paper
• State policy on disease prevention and healthy lifestyle formation in the Russian North: experience, innovation, perspectives

  2017cites this paper